Ultralife Co. (NASDAQ:ULBI) Director W. Shaw Robert Buys 2,500 Shares

Ultralife Co. (NASDAQ:ULBI) Director W. Shaw Robert bought 2,500 shares of the company’s stock in a transaction dated Tuesday, November 12th. The stock was purchased at an average price of $7.91 per share, for a total transaction of $19,775.00. Following the purchase, the director now owns 65,250 shares of the company’s stock, valued at approximately $516,127.50. This represents a 0.00 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Ultralife Trading Up 0.6 %

Shares of ULBI opened at $8.00 on Wednesday. The company has a 50 day simple moving average of $9.09 and a two-hundred day simple moving average of $10.32. Ultralife Co. has a 1 year low of $6.36 and a 1 year high of $13.39. The company has a debt-to-equity ratio of 0.07, a current ratio of 4.07 and a quick ratio of 2.06. The firm has a market cap of $132.96 million, a P/E ratio of 14.55 and a beta of 0.98.

Institutional Trading of Ultralife

Institutional investors have recently bought and sold shares of the stock. O Shaughnessy Asset Management LLC bought a new stake in shares of Ultralife in the first quarter valued at about $100,000. Rhumbline Advisers grew its stake in shares of Ultralife by 1,728.3% during the second quarter. Rhumbline Advisers now owns 11,811 shares of the technology company’s stock worth $125,000 after acquiring an additional 11,165 shares during the last quarter. Perritt Capital Management Inc. lifted its holdings in shares of Ultralife by 25.0% during the first quarter. Perritt Capital Management Inc. now owns 15,000 shares of the technology company’s stock worth $132,000 after purchasing an additional 3,000 shares during the period. Juncture Wealth Strategies LLC acquired a new stake in shares of Ultralife during the third quarter worth about $165,000. Finally, Hillsdale Investment Management Inc. acquired a new stake in shares of Ultralife during the first quarter worth about $166,000. 30.68% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut Ultralife from a “strong-buy” rating to a “buy” rating in a report on Thursday, October 3rd.

About Ultralife

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.